Recon: FDA greenlights first-ever vaccine targeting RSV; Eli Lilly plans to seek FDA approval for Alzheimer’s drug
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy